Denture Stomatitis Differential Diagnosis: A Comprehensive Guide for Dental Professionals

Oral candidiasis, a common fungal infection primarily caused by Candida albicans, manifests in various forms within the oral cavity. While often secondary to immune suppression, either local or systemic, its diverse presentations require a thorough understanding for accurate diagnosis and effective management. Denture stomatitis, also known as chronic atrophic candidiasis, represents a significant clinical entity within oral candidiasis, particularly prevalent among denture wearers. This article aims to provide an in-depth exploration of denture stomatitis, focusing on its differential diagnosis, and is designed to serve as an enhanced resource for dental professionals seeking to optimize their diagnostic and treatment strategies.

Etiology and Pathophysiology of Denture Stomatitis

Denture stomatitis is characterized by an inflammatory condition of the oral mucosa that underlies a removable denture, most frequently the upper denture. While Candida species, particularly Candida albicans, are the primary etiological agents, denture stomatitis is often multifactorial. The pathogenesis involves a complex interplay of factors, including:

• Candida Overgrowth: The warm, moist, and anaerobic environment under a denture, combined with the denture acting as a reservoir for Candida, promotes fungal proliferation.
• Trauma and Irritation: Ill-fitting dentures or continuous denture wear can cause chronic mechanical trauma to the mucosa, weakening the mucosal barrier and facilitating Candida invasion.
• Reduced Salivary Flow: Saliva plays a crucial role in oral hygiene and antifungal defense. Denture coverage can impede salivary flow to the underlying mucosa, creating a more susceptible environment.
• Biofilm Formation: Candida and bacteria can form a biofilm on the denture surface, enhancing fungal colonization and resistance to antifungal agents.
• Host Immune Response: While often associated with local factors, systemic conditions that compromise the immune system, such as diabetes, nutritional deficiencies, and immunosuppressive therapies, can increase susceptibility to denture stomatitis.

Clinical Presentation of Denture Stomatitis

Denture stomatitis classically presents as localized erythema of the palatal mucosa directly under the denture. However, the clinical appearance can vary, leading to classification systems that aid in diagnosis and management. The most widely used classification system, proposed by Newton, categorizes denture stomatitis into three types:

• Type I (Punctate or Localized Inflammation): Characterized by pin-point areas of inflammation or petechial hemorrhage, often representing early-stage denture stomatitis.
• Type II (Erythematous or Generalized Simple Inflammation): The most common type, presenting as diffuse erythema of the mucosa in contact with the denture base. The affected area is typically well-defined and conforms to the denture-bearing area.
• Type III (Papillary Hyperplasia or Granular Type): Also known as inflammatory papillary hyperplasia, this type is characterized by a pebbly or papillary appearance of the palatal mucosa, often in the central palate. This represents a more chronic and severe form of denture stomatitis.

Patients with denture stomatitis may be asymptomatic, especially in milder cases. When symptoms are present, they can include:

• Oral burning or soreness under the denture
• Dry mouth sensation
• Unpleasant taste
• Increased mucosal sensitivity

It’s crucial to note that angular cheilitis, an inflammation at the corners of the mouth, frequently coexists with denture stomatitis, further indicating a candidal involvement.

Denture Stomatitis Differential Diagnosis

While denture stomatitis is a common condition with recognizable features, several other oral mucosal conditions can mimic its clinical presentation. A thorough differential diagnosis is essential to ensure accurate diagnosis and appropriate management. The differential diagnosis of denture stomatitis includes:

1. Allergic Contact Stomatitis

Distinguishing Features: Allergic contact stomatitis can arise from denture materials (e.g., acrylic, metal components) or denture cleansers. Unlike denture stomatitis, which is primarily infective, allergic stomatitis is an immune-mediated hypersensitivity reaction.

• Clinical Presentation: Erythema, edema, and sometimes vesiculation or ulceration of the mucosa under the denture. The pattern may be less defined by the denture border and can extend beyond the denture-bearing area. Patients may report itching or burning.
• Key Differentiators:
  • History: Recent change in denture materials or cleansers may suggest an allergic etiology. Patch testing can confirm allergy to specific denture components.
  • Distribution: Allergic reactions may not be as confined to the denture-bearing area as denture stomatitis.
  • Response to Antifungals: Allergic stomatitis will not respond to antifungal therapy.
  • Biopsy: Histopathology may show spongiosis and eosinophilic infiltration, features less common in denture stomatitis.

2. Traumatic Ulceration

Distinguishing Features: Traumatic ulceration is caused by physical injury, often from ill-fitting dentures, sharp denture borders, or excessive occlusal forces.

• Clinical Presentation: Discrete ulcers, often with a white or yellowish pseudomembrane, surrounded by erythema. Ulcers are typically painful and may not conform precisely to the denture-bearing area.
• Key Differentiators:
  • History: Recent denture adjustments or known ill-fitting dentures are suggestive.
  • Ulcer Morphology: Ulcers are more focal and deeper than the diffuse erythema of denture stomatitis.
  • Pain: Pain is a prominent symptom of traumatic ulceration, often more intense than the discomfort associated with denture stomatitis.
  • Response to Antifungals: Traumatic ulcers will not resolve with antifungal treatment.
  • Denture Examination: Careful examination of the denture may reveal sharp edges or areas of overextension causing trauma.

3. Nutritional Deficiencies

Distinguishing Features: Certain nutritional deficiencies, particularly vitamin B deficiencies (e.g., riboflavin, niacin, folic acid, B12) and iron deficiency anemia, can manifest as oral mucosal changes, including glossitis and stomatitis.

• Clinical Presentation: Generalized glossitis (inflammation of the tongue), angular cheilitis, and generalized mucosal pallor or erythema. While denture stomatitis is localized under the denture, nutritional deficiencies tend to have more widespread oral manifestations.
• Key Differentiators:
  • Systemic Symptoms: Patients may present with other systemic symptoms of nutritional deficiencies, such as fatigue, weakness, pallor, or neurological symptoms.
  • Tongue Involvement: Glossitis is a hallmark of nutritional deficiencies, often affecting the tongue in addition to the denture-bearing mucosa.
  • Blood Tests: Complete blood count and serum vitamin levels can confirm nutritional deficiencies.
  • Response to Antifungals: Nutritional deficiency stomatitis will not improve with antifungal therapy.

4. Burning Mouth Syndrome (BMS)

Distinguishing Features: BMS is a chronic pain condition characterized by burning sensations in the oral mucosa, often in the absence of visible mucosal lesions. While denture stomatitis can cause oral burning, BMS is a distinct entity.

• Clinical Presentation: Patients report chronic burning, stinging, or scalding sensations in the mouth, often affecting the tongue, palate, and lips. Clinical examination typically reveals normal-appearing mucosa or minimal erythema.
• Key Differentiators:
  • Pain Characteristics: BMS pain is typically chronic, daily, and may fluctuate in intensity. It often lacks the distinct erythema confined to the denture area seen in denture stomatitis.
  • Lack of Visible Lesions: In many cases of BMS, the oral mucosa appears clinically normal.
  • Psychological Factors: BMS is often associated with psychological factors such as anxiety and depression.
  • Response to Antifungals: BMS will not respond to antifungal treatment.
  • Diagnostic Criteria: BMS is diagnosed based on exclusion of other conditions and meeting specific diagnostic criteria, including chronic oral burning pain, normal oral mucosa on examination, and exclusion of other medical or dental causes.

5. Oral Lichen Planus (Erythematous Form)

Distinguishing Features: Erythematous lichen planus is a variant of oral lichen planus that presents as red, atrophic lesions. While classic lichen planus is characterized by white, reticular lesions, the erythematous form can mimic denture stomatitis.

• Clinical Presentation: Diffuse or patchy erythema, often with atrophy of the mucosa. Fine white striae (Wickham’s striae), a hallmark of lichen planus, may be present at the periphery of erythematous areas, but can be subtle or absent.
• Key Differentiators:
  • White Striae: Careful examination may reveal subtle Wickham’s striae, especially at the borders of the lesion.
  • Distribution: Erythematous lichen planus can occur in various oral locations, not solely confined to the denture-bearing area.
  • Other Forms of Lichen Planus: Patients may have other forms of lichen planus elsewhere in the mouth (reticular, papular, ulcerative) or on the skin.
  • Biopsy: Histopathology of lichen planus shows characteristic features, including a band-like lymphocytic infiltrate in the lamina propria and basal cell liquefaction.

6. Erythroplakia

Distinguishing Features: Erythroplakia is a red patch on the oral mucosa that cannot be clinically or pathologically diagnosed as any other condition. It is considered a premalignant lesion with a higher risk of dysplasia or carcinoma compared to leukoplakia.

• Clinical Presentation: Well-defined, velvety red patch on the oral mucosa. Erythroplakia is often asymptomatic but can be associated with mild irritation.
• Key Differentiators:
  • Appearance: Erythroplakia is typically a more intensely red and velvety lesion than denture stomatitis.
  • Location: While denture stomatitis is under dentures, erythroplakia can occur anywhere in the oral cavity.
  • Risk Factors: Risk factors for erythroplakia are similar to those for oral cancer (smoking, alcohol).
  • Biopsy: Biopsy is mandatory for erythroplakia to rule out dysplasia or carcinoma in situ.

7. Mucositis (Radiation or Chemotherapy-Induced)

Distinguishing Features: Oral mucositis is a common side effect of radiation therapy to the head and neck region and certain chemotherapeutic agents.

• Clinical Presentation: Erythema, edema, and ulceration of the oral mucosa. Mucositis is often painful and can significantly impact oral function.
• Key Differentiators:
  • History: Recent or ongoing radiation or chemotherapy treatment is a key indicator.
  • Timing: Mucositis typically develops during or shortly after cancer therapy.
  • Severity: Mucositis can be more severe and debilitating than denture stomatitis.
  • Response to Antifungals: While secondary candidal infections can complicate mucositis, the underlying mucositis will not resolve with antifungal therapy alone.

8. Anemia

Distinguishing Features: Anemia, particularly iron deficiency anemia, can cause oral mucosal pallor and, in some cases, generalized stomatitis.

• Clinical Presentation: Pale oral mucosa, glossitis, and angular cheilitis. Patients may also exhibit systemic symptoms of anemia, such as fatigue and weakness.
• Key Differentiators:
  • Pallor: Generalized pallor of the oral mucosa is a prominent feature of anemia.
  • Systemic Symptoms: Presence of systemic symptoms of anemia.
  • Blood Tests: Complete blood count and iron studies can confirm anemia.
  • Response to Antifungals: Anemia-related stomatitis will not respond to antifungal treatment.

Diagnostic Approach to Denture Stomatitis

A systematic approach is crucial for accurate diagnosis and differentiation of denture stomatitis from other mimicking conditions. The diagnostic process involves:

1. History Taking:

   • Detailed medical history, including systemic conditions (diabetes, immunocompromise), medications (steroids, antibiotics), and nutritional status.
   • Dental history, including duration of denture wear, denture hygiene practices, denture fit, and history of denture stomatitis.
   • Symptom assessment: onset, duration, location, character, and aggravating/relieving factors.

2. Clinical Examination:

   • Extraoral examination: assess for angular cheilitis, facial pallor, and signs of systemic disease.
   • Intraoral examination:
     • Evaluate the denture-bearing mucosa for erythema, edema, papillary hyperplasia, ulceration, and distribution of lesions.
     • Assess the tongue for glossitis and papillary atrophy.
     • Examine other oral mucosal sites for lesions suggestive of lichen planus, erythroplakia, or other conditions.
   • Denture examination: assess denture fit, stability, extension, surface texture, and hygiene.

3. Diagnostic Tests (Selective):

   • Cytology: Potassium hydroxide (KOH) preparation or Periodic acid–Schiff (PAS) stain of a mucosal scraping can quickly identify Candida hyphae and spores, confirming candidal involvement.
   • Culture: Fungal culture on Sabouraud dextrose agar can identify Candida species and assess antifungal susceptibility, particularly in refractory cases.
   • Biopsy: Indicated for:
     • Suspected chronic hyperplastic candidiasis due to malignant potential.
     • Lesions unresponsive to antifungal therapy.
     • Differential diagnosis requires histological confirmation (e.g., lichen planus, erythroplakia).
   • Blood Tests: Complete blood count, serum vitamin levels, and blood glucose levels may be indicated based on history and clinical findings to rule out underlying systemic conditions.
   • Allergy Testing: Patch testing may be considered if allergic contact stomatitis is suspected.

4. Therapeutic Trial (Empirical Antifungal Therapy):

   • In typical cases of suspected denture stomatitis, empirical topical antifungal therapy (e.g., nystatin, clotrimazole) can be initiated.
   • Resolution of erythema and symptoms following antifungal treatment supports the diagnosis of denture stomatitis.
   • Lack of response necessitates further investigation and consideration of alternative diagnoses.

Management of Denture Stomatitis

The management of denture stomatitis is multifaceted and aims to eliminate Candida infection, address predisposing factors, and restore mucosal health. Treatment strategies include:

1. Antifungal Therapy:

   • Topical Antifungals: First-line therapy for most cases. Options include nystatin suspension or cream, clotrimazole troches, and miconazole gel. These are applied directly to the affected mucosa and denture-fitting surface.
   • Systemic Antifungals: Reserved for severe, refractory, or widespread infections, or in immunocompromised patients. Fluconazole is commonly used.

2. Denture Hygiene and Care:

   • Denture Cleaning: Patients must be instructed on meticulous daily denture cleaning using a denture brush and appropriate denture cleanser to remove biofilm and Candida.
   • Denture Soaking: Soaking dentures overnight in antifungal solutions (e.g., nystatin solution, chlorhexidine) or denture cleansers can reduce Candida load.
   • Denture-Free Period: Advising patients to remove dentures at night allows the mucosa to breathe and reduces the anaerobic environment conducive to fungal growth.

3. Denture Adjustment or Replacement:

   • Improve Denture Fit: Ill-fitting dentures should be adjusted or relined to eliminate trauma and improve mucosal health.
   • Consider Denture Replacement: In cases of old, porous dentures that harbor significant Candida biofilm, denture replacement may be necessary.

4. Address Underlying Predisposing Factors:

   • Manage Systemic Conditions: Control diabetes, address nutritional deficiencies, and optimize immune status.
   • Review Medications: Assess and adjust medications that may contribute to immunosuppression or dry mouth.
   • Patient Education: Educate patients on risk factors, denture hygiene, and the importance of regular dental check-ups.

5. Treatment of Angular Cheilitis:

   • Topical antifungal creams (e.g., miconazole) and steroid creams (e.g., hydrocortisone) are often used in combination to treat angular cheilitis associated with denture stomatitis.

Conclusion

Denture stomatitis is a prevalent condition among denture wearers, significantly impacting oral health and quality of life. Accurate diagnosis is paramount, requiring a comprehensive understanding of its clinical presentations and a robust differential diagnosis to distinguish it from mimicking conditions. By systematically considering allergic contact stomatitis, traumatic ulceration, nutritional deficiencies, BMS, lichen planus, erythroplakia, mucositis, and anemia, dental professionals can refine their diagnostic acumen. A thorough diagnostic approach, incorporating history, clinical examination, selective diagnostic tests, and empirical therapy when appropriate, ensures that patients receive targeted and effective management, leading to improved oral health outcomes and enhanced patient well-being. Continued education and vigilance in recognizing the nuances of denture stomatitis and its differential diagnoses are essential for all practitioners providing care to denture-wearing populations.

References

1. Fangtham M, Magder LS, Petri MA. Oral candidiasis in systemic lupus erythematosus. Lupus. 2014 Jun;23(7):684-90. [PubMed: 24598219]
2. Sivabalan S, Mahadevan S, Srinath MV. Recurrent oral thrush. Indian J Pediatr. 2014 Apr;81(4):394-6. [PubMed: 24081895]
3. Millsop JW, Fazel N. Oral candidiasis. Clin Dermatol. 2016 Jul-Aug;34(4):487-94. [PubMed: 27343964]
4. Akpan A, Morgan R. Oral candidiasis. Postgrad Med J. 2002 Aug;78(922):455-9. [PMC free article: PMC1742467] [PubMed: 12185216]
5. Hellstein JW, Marek CL. Candidiasis: Red and White Manifestations in the Oral Cavity. Head Neck Pathol. 2019 Mar;13(1):25-32. [PMC free article: PMC6405794] [PubMed: 30693459]
6. Benito-Cruz B, Aranda-Romo S, López-Esqueda FJ, de la Rosa-García E, Rosas-Hernández R, Sánchez-Vargas LO. Oral Candida isolates and fluconazole susceptibility patterns in older Mexican women. Arch Gerontol Geriatr. 2016 Jul-Aug;65:204-10. [PubMed: 27088219]
7. Mahajan B, Bagul N, Desai R, Reddy M, Mahajan A, Shete A, Risbud A, Mane A. Pseudomembranous Type of Oral Candidiasis is Associated with Decreased Salivary Flow Rate and Secretory Immunoglobulin A Levels. Mycopathologia. 2015 Aug;180(1-2):75-80. [PubMed: 25682023]
8. Coronado-Castellote L, Jiménez-Soriano Y. Clinical and microbiological diagnosis of oral candidiasis. J Clin Exp Dent. 2013 Dec 01;5(5):e279-86. [PMC free article: PMC3892259] [PubMed: 24455095]
9. Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol. 1994 Aug;32(8):1923-9. [PMC free article: PMC263904] [PubMed: 7989544]
10. Redman RS. Prevalence of geographic tongue, fissured tongue, median rhomboid glossitis, and hairy tongue among 3,611 Minnesota schoolchildren. Oral Surg Oral Med Oral Pathol. 1970 Sep;30(3):390-5. [PubMed: 5270895]
11. Goregen M, Miloglu O, Buyukkurt MC, Caglayan F, Aktas AE. Median rhomboid glossitis: a clinical and microbiological study. Eur J Dent. 2011 Aug;5(4):367-72. [PMC free article: PMC3170022] [PubMed: 21912494]
12. Lewis MAO, Williams DW. Diagnosis and management of oral candidosis. Br Dent J. 2017 Nov 10;223(9):675-681. [PubMed: 29123282]
13. Odden K, Schenck K, Koppang H, Hurlen B. Candidal infection of the gingiva in HIV-infected persons. J Oral Pathol Med. 1994 Apr;23(4):178-83. [PubMed: 8046655]
14. Blatchford NR. Treatment of oral candidosis with itraconazole: a review. J Am Acad Dermatol. 1990 Sep;23(3 Pt 2):565-7. [PubMed: 2170476]
15. Lyu X, Zhao C, Yan ZM, Hua H. Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis. Drug Des Devel Ther. 2016;10:1161-71. [PMC free article: PMC4801147] [PubMed: 27042008]
16. Hellfritzsch M, Pottegård A, Pedersen AJ, Burghle A, Mouaanaki F, Hallas J, Grove EL, Damkier P. Topical Antimycotics for Oral Candidiasis in Warfarin Users. Basic Clin Pharmacol Toxicol. 2017 Apr;120(4):368-372. [PubMed: 27901310]
17. Zhang LW, Fu JY, Hua H, Yan ZM. Efficacy and safety of miconazole for oral candidiasis: a systematic review and meta-analysis. Oral Dis. 2016 Apr;22(3):185-95. [PubMed: 26456226]
18. Kaplan YC, Koren G, Ito S, Bozzo P. Fluconazole use during breastfeeding. Can Fam Physician. 2015 Oct;61(10):875-6. [PMC free article: PMC4607332] [PubMed: 26759844]
19. Lagman R, Davis M, LeGrand S, Walsh D, Parala A, Gamier P, Cothren B, Cheema B, Gopal S, Rybicki L. Single-Dose Fluconazole Therapy for Oral Thrush in Hospice and Palliative Medicine Patients. Am J Hosp Palliat Care. 2017 Aug;34(7):645-649. [PubMed: 27188880]
20. Brent NB. Thrush in the breastfeeding dyad: results of a survey on diagnosis and treatment. Clin Pediatr (Phila). 2001 Sep;40(9):503-6. [PubMed: 11583049]
21. Su CW, Gaskie S, Jamieson B, Triezenberg D. Clinical inquiries. What is the best treatment for oral thrush in healthy infants? J Fam Pract. 2008 Jul;57(7):484-5. [PubMed: 18625176]
22. Patil S, Rao RS, Majumdar B, Anil S. Clinical Appearance of Oral Candida Infection and Therapeutic Strategies. Front Microbiol. 2015;6:1391. [PMC free article: PMC4681845] [PubMed: 26733948]
23. Mueller SW, Kedzior SK, Miller MA, Reynolds PM, Kiser TH, Krsak M, Molina KC. An overview of current and emerging antifungal pharmacotherapy for invasive fungal infections. Expert Opin Pharmacother. 2021 Jul;22(10):1355-1371. [PubMed: 33878996]